@misc{indiciaee1e6ecbd41b6,
  title = {Lymphoma response to chimeric antigen receptor T cell therapy is driven by endogenous tumor-reactive CD8⁺ T cells},
  author = {Ziccheddu, B. and Savid-Frontera, C. and Saralamma, V. V. G. and Gatenbee, C. and Youssfi, A. A. and Chojnacka, M. and Menges, M. and Cuadrado-Delgado, L. and Durante, M. and Mullinax, J. and Reid, K. and Miranda, J. A. and Corallo, S. and Merritt, E. and Sawyer, W. and Augello, A. and Newsam, A. D. and Chahar, D. and Amador, C. and Spiegel, J. Y. and Davila, M. and Landgren, O. and Alderuccio, J. P. and Robertson-Tessi, M. and Atkins, R. and Usmani, S. and Jain, M. D. and Anderson, A. R. A. and Maura, F. and Schatz, J. H. and Locke, F. L.},
  year = {2026},
  doi = {10.64898/2026.10.23.761341},
  url = {https://www.biorxiv.org/content/10.64898/2026.10.23.761341v1},
  note = {Source identifier: 10.64898/2026.10.23.761341}
}